Provide customers with a flexible approach to improve cycle times, limit costs, and reduce risk. We Specialize in the planning, management, execution, and analysis of Phase 2-3 clinical trials.

We help you leverage preclinical data in designing programs that bring your drug candidates to proof of concept. We have expertise in all clinical pharmacology studies for regulatory submissions, in a wide range of therapeutic areas, for small molecule, biological, and 505(b) applications ( 2) or Hybrid, on behalf of pharmaceutical companies of all sizes.